From an Enterprise to an Era
May 19 – 20, 2022 • Ritz-Carlton Laguna Niguel, Dana Point, CA
2022 Organizing Committee
The Annual Personalized Medicine Conference is organized by a cross-industry, cross-disciplinary panel, made up of providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of personalized medicine.
EDWARD ABRAHAMS, PH.D.
President, Personalized Medicine Coalition
Bonnie J. Addario
Co-Founder, Board Chair, GO2 Foundation for Lung Cancer
Antonio L. Andreu, M.D., Ph.D.
Scientific Director, EATRIS (European Infrastructure for Translational Medicine)
Senior Director, Public Policy and Reimbursement, Genentech
Director, Strategic Alliance Development, Federal Government Affairs, Bristol Myers Squibb
William Dalton, Ph.D., M.D.
Founder, Senior Advisor, M2Gen
Stephen L. Eck, M.D., Ph.D.
Senior Vice President, Clinical Development, Chief Medical Officer, MacroGenics
Okan Ekinci, M.D.
Senior Vice President, Global Head of Marketing and Innovation, Roche Diagnostics Information Solutions
Lori Frank, Ph.D.
Senior Vice President, Research, Policy, and Programs, The New York Academy of Medicine; Medical, Scientific, and Memory Screening Advisory Board Member, Alzheimer’s Foundation of America
Richard Hamermesh, D.B.A.
Co-Faculty Chair, Harvard Business School Kraft Precision Medicine Accelerator
Kris Joshi, Ph.D.
Executive Vice President, President, Network Solutions, Change Healthcare
President, American Association of Kidney Patients
Anne-Marie Martin, Ph.D.
Senior Vice President, Global Head of Experimental Medicine, GlaxoSmithKline
Founder, CEO, Genome Creative
Howard McLeod, Pharm.D.
Executive Clinical Director, Precision Health, Intermountain Healthcare
Founder, Managing Partner, GreyBird Ventures
Lincoln Nadauld, M.D., Ph.D.
Vice President, Chief of Precision Health and Academics, Intermountain Healthcare
Michael J. Pellini, M.D.
Managing Partner, Section 32
Vice President, Global Head of Market Access, Illumina
Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Pfizer
Michael Sherman, M.D.
Executive Vice President, Chief Medical Officer, Point32Health
Senior Vice President, External Affairs, Tempus
Ralph Snyderman, M.D.
James B. Duke Distinguished Professor of Medicine, Duke University
Mark P. Stevenson
Board Member, Personalized Medicine Coalition
Apostolia M. Tsimberidou, M.D., Ph.D.
Professor, The University of Texas MD Anderson Cancer Center
Alex Vadas, Ph.D.
Managing Director, Partner, LEK Consulting
Strategic Partnerships and Alliances Leader, Janssen Pharmaceutical Companies of Johnson & Johnson
Jay G. Wohlgemuth, M.D.
Chief Medical Officer, Senior Vice President, Research and Development, Medical, Population Health, Quest Diagnostics